CN Patent

CN102821801A — 药物递送装置

Assigned to Estral Medical Co · Expires 2012-12-12 · 13y expired

What this patent protects

用于手动地穿刺和注射的注射装置，包括：远侧壳体部(10)；具有多室容器(20)的近侧壳体部(12)；柱塞杆(40)；推压按钮(70)；起动构件(30)；驱动力器件(100)和锁止构件(50)，其中该装置还包括被安排成产生注射已经开始的可听到和触知的信号的导杆(60)。

USPTO Abstract

用于手动地穿刺和注射的注射装置，包括：远侧壳体部(10)；具有多室容器(20)的近侧壳体部(12)；柱塞杆(40)；推压按钮(70)；起动构件(30)；驱动力器件(100)和锁止构件(50)，其中该装置还包括被安排成产生注射已经开始的可听到和触知的信号的导杆(60)。

Drugs covered by this patent

testosterone-enanthate (TESTOSTERONE ENANTHATE)

Patent Metadata

Patent number: CN102821801A
Jurisdiction: CN
Classification: —
Expires: 2012-12-12
Drug substance claim: No
Drug product claim: No
Assignee: Estral Medical Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.